Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation

Title
Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
Authors
Keywords
Recurrent hepatocellular carcinoma, Liver transplantation, Sorafenib, mTORi
Journal
LANGENBECKS ARCHIVES OF SURGERY
Volume 398, Issue 8, Pages 1123-1128
Publisher
Springer Nature
Online
2013-10-03
DOI
10.1007/s00423-013-1114-1

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search